Clincosm LogoSign in Get a demo

Age-related Macular Degeneration

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

Recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • i-Lumen(TM) AMD
  • i-Lumen(TM) AMD Sham
  • Phoenix, Arizona
  • +2 more
Sep 1, 2022

Age-related Macular Degeneration Trial in United States (MT-0814, Placebo)

Terminated
Has Results
  • Age-related Macular Degeneration
  • Peoria, Arizona
  • +12 more
Mar 24, 2021

Geographic Atrophy, Age-related Macular Degeneration Trial in United States (LFG316, Sham, LFG316 Lower dose)

Completed
Has Results
  • Geographic Atrophy
  • Age-related Macular Degeneration
  • Phoenix, Arizona
  • +18 more
Dec 9, 2020

Age-Related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Phoenix, Abilene, Arecibo

Completed
Has Results
  • Age-Related Macular Degeneration
  • +5 more
  • brolucuzumab 6 mg IVT
  • Phoenix, Arizona
  • +2 more
Dec 9, 2020

Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +206 more
Sep 29, 2020

Choroidal Neovascularization, Age-related Macular Degeneration Trial in United States (hI-con1, ranibizumab, Sham injection)

Completed
Has Results
  • Choroidal Neovascularization
  • Age-related Macular Degeneration
  • hI-con1
  • +2 more
  • Phoenix, Arizona
  • +47 more
Sep 23, 2020

Age-related Macular Degeneration Trial in Worldwide (AGN-150998, ranibizumab, Sham Injection)

Completed
Has Results
  • Age-related Macular Degeneration
  • Phoenix, Arizona
  • +7 more
Apr 9, 2019

Age-Related Macular Degeneration Trial in United States (Fovista®, bevacizumab, ranibizumab)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +23 more
Feb 8, 2019

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +114 more
Aug 8, 2018

Age-related Macular Degeneration Trial in United States (Implantable Miniature Telescope (IMT))

Unknown status
  • Age-related Macular Degeneration
  • Implantable Miniature Telescope (IMT)
  • Phoenix, Arizona
  • +13 more
Apr 25, 2018

Age-Related Macular Degeneration Trial in United States (DE-120, Aflibercept)

Completed
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +13 more
Apr 16, 2018

Age-related Macular Degeneration Trial in United States (Squalamine lactate ophthalmic solution, 0.2%, Placebo Ophthalmic

Unknown status
  • Age-related Macular Degeneration
  • Squalamine lactate ophthalmic solution, 0.2%
  • +2 more
  • Mobile, Alabama
  • +117 more
Apr 25, 2017

Age-related Macular Degeneration Trial in United States (Ranibizumab)

Completed
Has Results
  • Age-related Macular Degeneration
  • Phoenix, Arizona
  • +98 more
Dec 11, 2012

Age-related Macular Degeneration, Choroidal Neovascularization Trial in Phoenix (Sirolimus)

Terminated
  • Age-related Macular Degeneration
  • Choroidal Neovascularization
  • Phoenix, Arizona
    Retinal Consultants of Arizona
Jan 8, 2013

Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Phoenix (Sirolimus in combination with ranibizumab,

Terminated
  • Age-Related Macular Degeneration
  • Choroidal Neovascularization
  • Sirolimus in combination with ranibizumab
  • Placebo in combination with ranibizumab
  • Phoenix, Arizona
    Retinal Consultants of Arizona
Jan 8, 2013

Age-Related Macular Degeneration Trial in Worldwide (AG-013,958)

Terminated
  • Age-Related Macular Degeneration
  • Mesa, Arizona
  • +38 more
May 26, 2011